Industries > Pharma > Global Transplant Market Forecast 2019-2029

Global Transplant Market Forecast 2019-2029

Tissue Products, Immunosuppressive Drugs, Preservation Solutions, Tissue Transplant, Organ Transplant, Heart Valve, Vascular Grafts, Bone Grafts, Cornea, Skin Grafts, Bone Marrow, Other Tissues, Kidney Transplant, Liver Transplant, Heart Transplant, Lung Transplant, Pancreas Transplant, Other Transplant, Hospitals, Transplant Centres, Other End-Users

PUBLISHED: 18 December 2018
PAGES: 184
PRODUCT CODE: PHA0346

Clear
WOOCS 2.2.1

The global transplant market will reach $29bn in 2019 and is estimated to grow at a CAGR of 9.9% from 2018- 2029. Visiongain estimated that Germany will hold 7.3% of the global transplant market.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 184-page report you will receive 82 tables and 55 figures– all unavailable elsewhere.

The 184-page report provides clear detailed insight into the transplant market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand-new report today you stay better informed and ready to act.

Report Scope

• Global Transplant Market from 2019-2029

• Forecast of the Global Transplant market by Product:
• Tissue Products
• Immunosuppressive Drugs
• Preservation Solutions

• Forecast of the Global Transplant market by Application:
• Tissue Transplant: Heart Valve, Vascular Grafts, Bone Grafts, Cornea, Skin Grafts, Bone Marrow, Other Tissues
• Organ Transplant: Kidney Transplant, Liver Transplant, Heart Transplant, Lung Transplant, Pancreas Transplant, Other Transplant

• Forecast of the Global Transplant market by End-user:
• Hospitals
• Transplant Centers
• Others

• This report provides individual revenue forecasts to 2029 for these regional and national markets:
• North America: US, Canada
• EU: Germany, France, United Kingdom, Italy, Spain and rest of EU
• Asia-Pacific: Japan, China, India and rest of Asia-Pacific
• RoW: Brazil, Mexico, Russia, South Africa and rest of ROW

• Our study discusses the selected leading companies that are the major players in the transplant market:
• AbbVie, Inc.
• Arthrex, Inc.
• Medtronic
• Novartis AG
• Stryker
• Teva Pharmaceuticals
• Veloxis Pharmaceuticals
• Zimmer Biomet

• This study discusses the competitive landscape, including factors that drive and restrain the transplant market

• This report also provides the number organ transplant procedures from 2012-2017 in selected countries:
• The US
• Canada
• Germany
• UK
• France
• Italy
• Spain
• Japan
• China
• Brazil
• Mexico
• South Africa
• Russia

Visiongain’s study is intended for anyone requiring commercial analyses for the transplant market. You find data, trends and predictions.

Buy our report today Global Transplant Market Analysis : Tissue Products, Immunosuppressive Drugs, Preservation Solutions, Tissue Transplant, Organ Transplant, Heart Valve, Vascular Grafts, Bone Grafts, Cornea, Skin Grafts, Bone Marrow, Other Tissues, Kidney Transplant, Liver Transplant, Heart Transplant, Lung Transplant, Pancreas Transplant, Other Transplant, Hospitals, Transplant Centres, Other End-Users.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Download sample pages

Complete the form below to download your free sample pages for Global Transplant Market Forecast 2019-2029


Download sample pages

Complete the form below to download your free sample pages for Global Transplant Market Forecast 2019-2029


Latest Pharma news

Visiongain Publishes Plasma Therapy Market Report 2021-2031

The market is forecasted for the next ten years based on market growth within each segment of the blood plasma products. The report study aims to explore the market drivers, restraints and also market opportunities facing blood plasma product stakeholders in different geographic areas.

26 November 2020

READ

Visiongain Publishes Precision Cancer Diagnostic Test Market Report 2021-2031

Molecular diagnostics are rapidly transforming drug development and patient selection: trials with biomarkers have higher success rates than those without, and combining patients with a proven biomarker allows efficient trials to be conducted in rare cancers.

26 November 2020

READ

Visiongain Publishes Top 50 Biosimilar Drug Manufacturers 2021

Growing demand for cost-effective drugs; rising prevalence of chronic diseases; mounting investment in drug R&D by biopharmaceutical companies; new product launches and rising acceptance of biosimilars in North America region are some of the major factors that propel the biosimilars market growth.

25 November 2020

READ

Visiongain Publishes Advanced Therapy Medicinal Products (ATMP) Market Report 2021-2031

Currently, the ATMP market is at a nascent stage and is expected to flourish during near future owing to increasing research and development activities and rising use of ATMP therapy products in treatment areas with low or no alternative treatment options support the market growth

24 November 2020

READ

Categories

Category